prontex capsula dura
laboratorio kemex s.a. - pomalidomida - capsula dura - pomalidomida 2 mg
prontex capsula dura
laboratorio kemex s.a. - pomalidomida - capsula dura - pomalidomida 3 mg
prontex capsula dura
laboratorio kemex s.a. - pomalidomida - capsula dura - pomalidomida 4 mg
impedice 1 mg
iclos uruguay s.a. uruguay - pomalidomida 1,00 mg - capsulas - cada cápsula contiene: pomalidomida 1,00 mg
sarclisa
sanofi winthrop industrie - isatuximab - mieloma múltiple - agentes antineoplásicos - sarclisa is indicated: in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma (mm) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (pi) and have demonstrated disease progression on the last therapy. in combination with carfilzomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy (see section 5.
pomalyst 2mg cápsulas duras
bristol-myers squibb pharma eeig [ie] ireland - pomalidomida 2mg - capsulas duras - cada cÁpsula dura de 2mg contiene: pomalidomida 2mg
pomalyst 4mg cápsulas
bristol-myers squibb pharma eeig [ie] ireland - pomalidomida 4mg - cÁpsulas duras - cada cÁpsula de 4mg contiene: pomalidomida 4mg
pomalyst 1mg cápsulas
bristol-myers squibb pharma eeig [ie] ireland - pomalidomida 1,00mg - capsulas duras - cada cápsula de 1mg contiene: pomalidomida 1,00mg
pomalyst 3mg cápsulas
bristol-myers squibb pharma eeig [ie] ireland - pomalidomida 3mg - cÁpsulas duras - cada cÁpsula de 3mg contiene: pomalidomida 3mg
pomelane 4 mg
laboratorio eczane pharma s.a. argentina - pomalidomida 4 mg - capsula dura - cada capsula dura contiene: pomalidomida 4 mg